Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,046 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells.
Che PP, Gregori A, Bergonzini C, Ali M, Mantini G, Schmidt T, Finamore F, Rodrigues SMF, Frampton AE, McDonnell LA, Danen EH, Slotman BJ, Sminia P, Giovannetti E. Che PP, et al. Among authors: ali m. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1328-1343. doi: 10.1016/j.ijrobp.2023.10.035. Epub 2023 Oct 31. Int J Radiat Oncol Biol Phys. 2024. PMID: 37914140
The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach.
Boyd LNC, Ali M, Kam L, Puik JR, Rodrigues SMF, Zwart ES, Daams F, Zonderhuis BM, Meijer LL, Le Large TYS, Giovannetti E, van Laarhoven HWM, Kazemier G. Boyd LNC, et al. Among authors: ali m. Cancers (Basel). 2022 Jan 11;14(2):344. doi: 10.3390/cancers14020344. Cancers (Basel). 2022. PMID: 35053506 Free PMC article.
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data.
Boyd LNC, Ali M, Leeflang MMG, Treglia G, de Vries R, Le Large TYS, Besselink MG, Giovannetti E, van Laarhoven HWM, Kazemier G. Boyd LNC, et al. Among authors: ali m. EClinicalMedicine. 2022 Nov 24;55:101747. doi: 10.1016/j.eclinm.2022.101747. eCollection 2023 Jan. EClinicalMedicine. 2022. PMID: 36457649 Free PMC article.
hENT1 as a Predictive Biomarker in PDAC-Letter.
Boyd LNC, Ali M, Puik JR, Meijer LL, Le Large TYS, van Laarhoven HWM, Giovannetti E, Kazemier G. Boyd LNC, et al. Among authors: ali m. Clin Cancer Res. 2023 Aug 1;29(15):2944. doi: 10.1158/1078-0432.CCR-22-3827. Clin Cancer Res. 2023. PMID: 37525961 No abstract available.
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers.
Boyd LNC, Ali M, Comandatore A, Garajova I, Kam L, Puik JR, Fraga Rodrigues SM, Meijer LL, Le Large TYS, Besselink MG, Morelli L, Frampton A, van Laarhoven HWM, Giovannetti E, Kazemier G. Boyd LNC, et al. Among authors: ali m. JAMA Netw Open. 2023 Aug 1;6(8):e2331197. doi: 10.1001/jamanetworkopen.2023.31197. JAMA Netw Open. 2023. PMID: 37639271 Free PMC article.
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study.
Boyd LNC, Nooijen LE, Ali M, Puik JR, Moustaquim J, Fraga Rodrigues SM, Broos R, Belkouz A, Meijer LL, Le Large TYS, Erdmann JI, Hooijer GKJ, Heger M, Van Laarhoven HWM, Roos E, Kazemier G, Giovannetti E, Verheij J, Klümpen HJ. Boyd LNC, et al. Among authors: ali m. Front Pharmacol. 2023 Oct 18;14:1274692. doi: 10.3389/fphar.2023.1274692. eCollection 2023. Front Pharmacol. 2023. PMID: 37920204 Free PMC article.
Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study.
Garajová I, Comandatore A, Boyd L, Ali M, Gelsomino F, de Lorenzo S, Pedrazzi G, Spallanzani A, Martinelli G, Balsano R, Leonardi F, Palmeri M, Kazemier G, Di Franco G, Guadagni S, Furbetta N, Gentiluomo M, Ramacciotti N, Di Candio G, Giovannetti E, Morelli L. Garajová I, et al. Among authors: ali m. BJS Open. 2024 Jan 3;8(1):zrad119. doi: 10.1093/bjsopen/zrad119. BJS Open. 2024. PMID: 38195161 Free PMC article. No abstract available.
Prognostic value of microRNA-21 in intra- and extrahepatic cholangiocarcinoma after radical resection: cohort study.
Boyd LNC, Ali M, Comandatore A, Brandi G, Tavolari S, Gaeta R, Meijer LL, Le Large TYS, Riefolo M, Vasuri F, Morelli L, van Laarhoven HWM, Giovannetti E, Kazemier G, Garajová I. Boyd LNC, et al. Among authors: ali m. BJS Open. 2024 Mar 1;8(2):zrae031. doi: 10.1093/bjsopen/zrae031. BJS Open. 2024. PMID: 38637298 Free PMC article. No abstract available.
Advances in target drugs and immunotherapy for biliary tract cancer.
Deiana C, Ricci C, Vahabi M, Ali M, Brandi G, Giovannetti E. Deiana C, et al. Among authors: ali m. Expert Rev Gastroenterol Hepatol. 2024 Oct;18(10):605-630. doi: 10.1080/17474124.2024.2416230. Epub 2024 Nov 15. Expert Rev Gastroenterol Hepatol. 2024. PMID: 39544174 Free article. Review.
Gemcitabine-cisplatin induction treatment in patients with locally advanced perihilar cholangiocarcinoma (IMPACCA): A prospective registration study.
Ten Haaft BHEA, Sickmann MMT, Nooijen LE, Ali M, Wilmink JW, Klümpen HJ, Swijnenburg RJ, Zonderhuis BM, Besselink MG, Kazemier G, Erdmann JI; for HPB-Amsterdam. Ten Haaft BHEA, et al. Among authors: ali m. Eur J Surg Oncol. 2024 Nov 6:109358. doi: 10.1016/j.ejso.2024.109358. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39638652 Free article.
14,046 results
You have reached the last available page of results. Please see the User Guide for more information.